ADMA BIOLOGICS INC's ticker is ADMA and the CUSIP is 000899104. A total of 215 filers reported holding ADMA BIOLOGICS INC in Q1 2024. The put-call ratio across all filers is 0.15 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $253,663 | +73.3% | 22,689 | +2.3% | 0.00% | – |
| Q1 2024 | $146,401 | +55.7% | 22,182 | +6.6% | 0.00% | – |
| Q4 2023 | $94,025 | +35.7% | 20,802 | 0.0% | 0.00% | – |
| Q3 2023 | $69,271 | -9.3% | 20,802 | 0.0% | 0.00% | – |
| Q2 2023 | $76,343 | +88.5% | 20,802 | +70.0% | 0.00% | – |
| Q1 2023 | $40,498 | -9.5% | 12,235 | +6.1% | 0.00% | – |
| Q4 2022 | $44,756 | +49.2% | 11,535 | -5.7% | 0.00% | – |
| Q3 2022 | $30,000 | -88.4% | 12,235 | -4.1% | 0.00% | – |
| Q2 2022 | $258,000 | – | 12,753 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prosight Management, LP | 883,214 | $1,722,000 | 0.80% |
| Telemetry Investments, L.L.C. | 200,615 | $391,000 | 0.66% |
| Perceptive Advisors | 16,584,802 | $32,340,000 | 0.35% |
| Consonance Capital Management LP | 1,558,290 | $3,039,000 | 0.28% |
| 683 Capital Management, LLC | 2,000,000 | $3,900,000 | 0.18% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 627,931 | $1,224,000 | 0.15% |
| GSA CAPITAL PARTNERS LLP | 327,052 | $638,000 | 0.10% |
| APOGEM CAPITAL LLC | 54,240 | $106,000 | 0.07% |
| HUSSMAN STRATEGIC ADVISORS, INC. | 82,000 | $160,000 | 0.04% |
| J. Goldman & Co LP | 376,319 | $734,000 | 0.04% |